Viking Therapeutics TodayVKTXViking Therapeutics$64.45 +1.51 (+2.40$8.28▼$99.41Price Target$108.60Add to WatchlistViking Therapeutics Inc. NASDAQ: VKTX, a clinical-stage biotechnology company with a market cap approaching $7 billion, is turning heads in 2024. Year to date, the stock has surged an impressive 238%, and its rise over the past 12 months has been even more dramatic, with shares climbing 326%.For a mid-cap biotech, these kinds of gains significantly outpace both the broader market ...